O00429 (DNM1L_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 112.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Dynamin-1-like protein EC=3.6.5.5 Alternative name(s): Dnm1p/Vps1p-like protein Short name=DVLP Dynamin family member proline-rich carboxyl-terminal domain less Short name=Dymple Dynamin-like protein Dynamin-like protein 4 Dynamin-like protein IV Short name=HdynIV Dynamin-related protein 1 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 736 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Functions in mitochondrial and peroxisomal division. Mediates membrane fission through oligomerization into ring-like structures which wrap around the scission site to constict and sever the mitochondrial membrane through a GTP hydrolysis-dependent mechanism. Required for normal brain development. Facilitates developmentally-regulated apoptosis during neural tube development. Required for a normal rate of cytochrome c release and caspase activation during apoptosis. Also required for mitochondrial fission during mitosis. Required for programmed necrosis execution. May be involved in vesicle transport. Ref.3 Ref.10 Ref.12 Ref.13 Ref.14 Ref.15 Ref.18 Ref.19 Ref.20 Ref.22 Ref.23 Ref.26 Ref.28 Ref.29 Ref.31 Ref.32 Isoform 1 and isoform 4 inhibit peroxisomal division when overexpressed. Ref.3 Ref.10 Ref.12 Ref.13 Ref.14 Ref.15 Ref.18 Ref.19 Ref.20 Ref.22 Ref.23 Ref.26 Ref.28 Ref.29 Ref.31 Ref.32 |
| Catalytic activity | GTP + H2O = GDP + phosphate. Ref.8 |
| Subunit structure | Homotetramer; dimerizes through the N-terminal GTP-middle region of one molecule binding to the GED domain of another DNM1L molecule. Can self-assemble in multimeric ring-like structures. Interacts with BCL2L1; the interaction stimulates the GTPase activity of DMN1L in synapses and increases the number of axonal mitochondria and the size and number of synaptic vesicle clusters. Interacts with FIS1 By similarity. Interacts with GSK3B and MARCH5. Interacts (via the GTPase and B domains) with UBE2I; the interaction promotes sumoylation of DNM1L, mainly in ite B domain. Interacts with PPP3CA; the interaction dephosphorylates DNM1L and regulates its transition to mitochondria. Interacts witn MID49 and MID51. Interacts with PGAM5; this interaction leads to dephosphorylation at Ser-637 and activation of GTPase activity and eventually to mitochondria fragmentation. Ref.2 Ref.4 Ref.11 Ref.12 Ref.15 Ref.16 Ref.17 Ref.20 Ref.23 Ref.26 Ref.28 Ref.35 Ref.36 Ref.38 |
| Subcellular location | Cytoplasm › cytosol. Golgi apparatus. Endomembrane system; Peripheral membrane protein. Mitochondrion outer membrane; Peripheral membrane protein. Note: Mainly cytosolic. Translocated to the mitochondrial membrane through O-GlcNAcylation and interaction with FIS1. Colocalized with MARCH5 at mitochondrial membrane. Localizes to mitochondria at sites of division. Localizes to mitochondria following necrosis induction. Associated with peroxisomal membranes, partly recruited there by PEX11B. May also be associated with endoplasmic reticulum tubules and cytoplasmic vesicles and found to be perinuclear. In some cell types, localizes to the Golgi complex. Ref.1 Ref.3 Ref.8 Ref.9 Ref.10 Ref.12 Ref.13 Ref.14 Ref.15 Ref.21 Ref.26 Ref.32 Ref.38 |
| Tissue specificity | Ubiquitously expressed with highest levels found in skeletal muscles, heart, kidney and brain. Isoform 1 is brain-specific. Isoform 2 and isoform 3 are predominantly expressed in testis and skeletal muscles respectively. Isoform 4 is weakly expressed in brain, heart and kidney. Isoform 5 is dominantly expressed in liver, heart and kidney. Isoform 6 is expressed in neurons. Ref.2 Ref.3 Ref.4 Ref.8 Ref.10 |
| Domain | The GED domain folds back to interact, in cis, with the GTP-binding domain and middle domain, and interacts, in trans, with the GED domains of other DNM1L molecules, and is thus critical for activating GTPase activity and for DNM1L dimerization. Ref.15 |
| Post-translational modification | Phosphorylation/dephosphorylation events on two sites near the GED domain regulate mitochondrial fission. Phosphorylation on Ser-637 inhibits mitochondrial fission probably through preventing intramolecular interaction. Dephosphorylated on this site by PPP3CA which promotes mitochondrial fission. Phosphorylation on Ser-616 also promotes mitochondrial fission. Ref.19 Ref.20 Ref.23 Ref.26 Sumoylated on various lysine residues within the B domain, probably by MUL1. Sumoylation positively regulates mitochondrial fission. Desumoylated by SENP5 during G2/M transition of mitosis. Appears to be linked to its catalytic activity. Ref.27 Ref.28 Ref.29 S-nitrosylation increases DNM1L dimerization, mitochondrial fission and causes neuronal damage. Ubiquitination by MARCH5 affects mitochondrial morphology. O-GlcNAcylation augments the level of the GTP-bound active form of DRP1 and induces translocation from the cytoplasm to mitochondria in cardiomyocytes. It also decreases phosphorylation at Ser-637 By similarity. |
| Involvement in disease | May be associated with Alzheimer disease through beta-amyloid-induced increased S-nitrosylation of DNM1L, which triggers, directly or indirectly, excessive mitochondrial fission, synaptic loss and neuronal damage. Ref.31 Encephalopathy, lethal, due to defective mitochondrial and peroxisomal fission (EMPF) [MIM:614388]: A rare autosomal dominant systemic disorder resulting in lack of neurologic development and death in infancy. After birth, infants present in the first week of life with poor feeding and neurologic impairment, including hypotonia, little spontaneous movement, no tendon reflexes, no response to light stimulation, and poor visual fixation. Other features include mildly elevated plasma concentration of very-long-chain fatty acids, lactic acidosis, microcephaly, deep-set eyes, optic atrophy and hypoplasia, and an abnormal gyral pattern in both frontal lobes associated with dysmyelination. |
| Sequence similarities | Belongs to the dynamin family. Contains 1 GED domain. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| ESR1 | P03372 | 2 | EBI-724571,EBI-78473 | |
| LRRK2 | Q5S007 | 7 | EBI-724571,EBI-5323863 |
Alternative products
| This entry describes 6 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: O00429-1) Also known as: HdynIV-WT; DLP1F; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 4 (identifier: O00429-2) Also known as: HdynIV-11; DLP1c; The sequence of this isoform differs from the canonical sequence as follows: 559-569: Missing. | ||||||
| Isoform 2 (identifier: O00429-3) Also known as: DLP1a; The sequence of this isoform differs from the canonical sequence as follows: 533-558: Missing. | ||||||
| Isoform 3 (identifier: O00429-4) Also known as: HdynIV-37; DLP1b; The sequence of this isoform differs from the canonical sequence as follows: 533-569: Missing. | ||||||
| Isoform 5 (identifier: O00429-5) Also known as: HdynIV-26; The sequence of this isoform differs from the canonical sequence as follows: 544-569: Missing. | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 6 (identifier: O00429-6) The sequence of this isoform differs from the canonical sequence as follows: 83-83: N → NDPATWKNSRHLSK |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 736 | 736 | Dynamin-1-like protein | PRO_0000206566 | |||||
Regions | |||||||||
| Domain | 644 – 735 | 92 | GED | ||||||
| Nucleotide binding | 32 – 39 | 8 | GTP By similarity | ||||||
| Nucleotide binding | 146 – 150 | 5 | GTP By similarity | ||||||
| Nucleotide binding | 215 – 218 | 4 | GTP By similarity | ||||||
| Region | 1 – 343 | 343 | GTPase domain | ||||||
| Region | 344 – 489 | 146 | Middle domain | ||||||
| Region | 448 – 685 | 238 | Interaction with GSK3B | ||||||
| Region | 502 – 569 | 68 | B domain | ||||||
Amino acid modifications | |||||||||
| Modified residue | 529 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 548 | 1 | Phosphoserine Ref.25 | ||||||
| Modified residue | 607 | 1 | Phosphoserine Ref.25 | ||||||
| Modified residue | 616 | 1 | Phosphoserine; by CDK1 Ref.24 Ref.25 Ref.26 Ref.30 Ref.33 Ref.37 | ||||||
| Modified residue | 637 | 1 | Phosphoserine; by CAMK1 and PKA Ref.20 Ref.23 Ref.26 | ||||||
| Modified residue | 644 | 1 | S-nitrosocysteine Ref.31 | ||||||
| Glycosylation | 585 | 1 | O-linked (GlcNAc...) | ||||||
| Glycosylation | 586 | 1 | O-linked (GlcNAc...) | ||||||
| Cross-link | 532 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO) Ref.28 | |||||||
| Cross-link | 535 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO) Ref.28 | |||||||
| Cross-link | 558 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO) Ref.28 | |||||||
| Cross-link | 568 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO) Ref.28 | |||||||
| Cross-link | 594 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO) Probable | |||||||
| Cross-link | 597 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO) Ref.28 | |||||||
| Cross-link | 606 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO) Probable | |||||||
| Cross-link | 608 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO) Ref.28 | |||||||
Natural variations | |||||||||
| Alternative sequence | 83 | 1 | N → NDPATWKNSRHLSK in isoform 6. | VSP_039097 | |||||
| Alternative sequence | 533 – 569 | 37 | Missing in isoform 3. | VSP_013685 | |||||
| Alternative sequence | 533 – 558 | 26 | Missing in isoform 2. | VSP_013686 | |||||
| Alternative sequence | 544 – 569 | 26 | Missing in isoform 5. | VSP_013687 | |||||
| Alternative sequence | 559 – 569 | 11 | Missing in isoform 4. | VSP_013688 | |||||
| Natural variant | 71 | 1 | S → T. Ref.2 Ref.3 Ref.4 Corresponds to variant rs1064610 [ dbSNP | Ensembl ]. | VAR_022446 | |||||
| Natural variant | 395 | 1 | A → D in EMPF; the mutation acts in a dominant-negative manner; defects observed in both mitochondrial and peroxisomal fission. Ref.22 | VAR_063704 | |||||
| Natural variant | 426 | 1 | E → D. Corresponds to variant rs2389105 [ dbSNP | Ensembl ]. | VAR_030489 | |||||
Experimental info | |||||||||
| Mutagenesis | 38 | 1 | K → A: Loss of GTPase activity. Impairs mitochondrial division and induces changes in peroxisome morphology. No effect on oligomerization. Increase in sumoylation by SUMO3. Ref.3 Ref.12 Ref.13 Ref.15 Ref.28 | ||||||
| Mutagenesis | 38 | 1 | K → E: Overexpression delays protein secretion. Ref.3 Ref.12 Ref.13 Ref.15 Ref.28 | ||||||
| Mutagenesis | 39 | 1 | S → I: Decreased localization to the perinuclear region. Ref.8 Ref.14 | ||||||
| Mutagenesis | 39 | 1 | S → N: Reduces peroxisomal abundance. Ref.8 Ref.14 | ||||||
| Mutagenesis | 41 | 1 | V → F: Temperature-sensitive. Impairs mitochondrial division. Ref.12 | ||||||
| Mutagenesis | 59 | 1 | T → A: Impairs mitochondrial division. Reduces peroxisomal abundance. Ref.12 Ref.14 | ||||||
| Mutagenesis | 281 | 1 | G → D: Temperature-sensitive. Impairs mitochondrial division. Ref.12 | ||||||
| Mutagenesis | 300 | 1 | C → A: No effect on S-nitrosylation. Ref.31 | ||||||
| Mutagenesis | 345 | 1 | C → A: No effect on S-nitrosylation. Ref.31 | ||||||
| Mutagenesis | 361 | 1 | C → A: No effect on S-nitrosylation. Ref.31 | ||||||
| Mutagenesis | 367 | 1 | C → A: No effect on S-nitrosylation. Ref.31 | ||||||
| Mutagenesis | 431 | 1 | C → A: No effect on S-nitrosylation. Ref.31 | ||||||
| Mutagenesis | 446 | 1 | C → A: No effect on S-nitrosylation. Ref.31 | ||||||
| Mutagenesis | 470 | 1 | C → A: No effect on S-nitrosylation. Ref.31 | ||||||
| Mutagenesis | 505 | 1 | C → A: No effect on S-nitrosylation. Ref.31 | ||||||
| Mutagenesis | 532 | 1 | K → R: Some loss of sumoylation in B domain. Complete loss of sumoylation in B domain; when associated with R-535; R-558 and R-568. Ref.28 | ||||||
| Mutagenesis | 535 | 1 | K → R: Some loss of sumoylation in B domain. Complete loss of sumoylation in B domain; when associated with R-532; R-558 and R-568. Ref.28 | ||||||
| Mutagenesis | 558 | 1 | K → R: Some loss of sumoylation in B domain. Complete loss of sumoylation in B domain; when associated with R-532; R-535 and R-568. Ref.28 | ||||||
| Mutagenesis | 568 | 1 | K → R: Some loss of sumoylation in B domain. Complete loss of sumoylation in B domain; when associated with R-532; R-535 and R-558. Ref.28 | ||||||
| Mutagenesis | 594 | 1 | K → R: Some loss of sumoylation in the GED domain; Complete loss of sumoylation in the GED domain; when associated with R-597; R-606 and R-608. Ref.28 | ||||||
| Mutagenesis | 597 | 1 | K → R: Some loss of sumoylation in the GED domain; Complete loss of sumoylation in the GED domain; when associated with R-594; R-606 and R-608. Ref.28 | ||||||
| Mutagenesis | 606 | 1 | K → R: Some loss of sumoylation in the GED domain; Complete loss of sumoylation in the GED domain; when associated with R-594; R-597 and R-608. Ref.28 | ||||||
| Mutagenesis | 608 | 1 | K → R: Some loss of sumoylation in the GED domain; Complete loss of sumoylation in the GED domain; when associated with R-594; R-597 and R-606. Ref.28 | ||||||
| Mutagenesis | 616 | 1 | S → A: Little effect on mitochondrial morphology. Translocated to mitochondria. Ref.26 | ||||||
| Mutagenesis | 637 | 1 | S → A: Abolishes phosphorylation. Promotes mitochondrial fission and cell vulnerability to apoptotic insults. Mostly mitochondrial. Disrupts, in vitro, binding to FIS1. Ref.20 Ref.23 Ref.26 | ||||||
| Mutagenesis | 637 | 1 | S → D: Impairs intramolecular, but not intermolecular interactions. Slight reduction in GTPase activity. Inhibits mitochondrial fission. Retained in cytoplasm. Ref.20 Ref.23 Ref.26 | ||||||
| Mutagenesis | 644 | 1 | C → A: Abolishes S-nitrosylation. Reduced dimerization and no enhancement of GTPase activity. Ref.31 | ||||||
| Mutagenesis | 679 | 1 | K → A: Diminishes intermolecular interaction between GTP-middle domain and GED domain but no effect on oligomerization. Marked reduction in GTPase activity, in vitro. Decreased mitochondrial division. Ref.15 | ||||||
| Sequence conflict | 208 | 1 | R → C in AAC35283. Ref.2 | ||||||
| Sequence conflict | 208 | 1 | R → C in AAD39541. Ref.4 | ||||||
Sequences
| ||||||||||||||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Identification and subcellular localization of a novel mammalian dynamin-related protein homologous to yeast Vps1p and Dnm1p." Shin H.-W., Shinotsuka C., Torii S., Murakami K., Nakayama K. J. Biochem. 122:525-530(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION. Tissue: Hepatoma. |
| [2] | "Human dynamin-like protein interacts with the glycogen synthase kinase 3beta." Hong Y.-R., Chen C.-H., Cheng D.-S., Howng S.-L., Chow C.-C. Biochem. Biophys. Res. Commun. 249:697-703(1998) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), VARIANT THR-71, TISSUE SPECIFICITY, INTERACTION WITH GSK3B. Tissue: Liver. |
| [3] | "Identification and functional characterization of a novel human protein highly related to the yeast dynamin-like GTPase Vps1p." Imoto M., Tachibana I., Urrutia R. J. Cell Sci. 111:1341-1349(1998) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT THR-71, TISSUE SPECIFICITY, SUBCELLULAR LOCATION, MUTAGENESIS OF LYS-38, FUNCTION. Tissue: Brain. |
| [4] | "Differential expression of four human dynamin-like protein variants in brain tumors." Chen C.-H., Howng S.-L., Hwang S.-L., Chou C.-K., Liao C.-H., Hong Y.-R. DNA Cell Biol. 19:189-194(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 3; 4 AND 5), VARIANT THR-71, TISSUE SPECIFICITY, INTERACTION WITH GSK3B. Tissue: Brain. |
| [5] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 6). Tissue: Brain. |
| [6] | "The finished DNA sequence of human chromosome 12." Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R. Gibbs R.A.Nature 440:346-351(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [7] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 27-736 (ISOFORM 1). Tissue: Lung. |
| [8] | "Dymple, a novel dynamin-like high molecular weight GTPase lacking a proline-rich carboxyl-terminal domain in mammalian cells." Kamimoto T., Nagai Y., Onogi H., Muro Y., Wakabayashi T., Hagiwara M. J. Biol. Chem. 273:1044-1051(1998) [PubMed] [Europe PMC] [Abstract] Cited for: MUTAGENESIS OF SER-39, TISSUE SPECIFICITY, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION. |
| [9] | "A novel dynamin-like protein associates with cytoplasmic vesicles and tubules of the endoplasmic reticulum in mammalian cells." Yoon Y., Pitts K.R., Dahan S., McNiven M.A. J. Cell Biol. 140:779-793(1998) [PubMed] [Europe PMC] [Abstract] Cited for: SUBCELLULAR LOCATION. |
| [10] | "A human dynamin-related protein controls the distribution of mitochondria." Smirnova E., Shurland D.-L., Ryazantsev S.N., van der Bliek A.M. J. Cell Biol. 143:351-358(1998) [PubMed] [Europe PMC] [Abstract] Cited for: TISSUE SPECIFICITY, SUBCELLULAR LOCATION, FUNCTION. |
| [11] | "Intermolecular and interdomain interactions of a dynamin-related GTP-binding protein, Dnm1p/Vps1p-like protein." Shin H.-W., Takatsu H., Mukai H., Munekata E., Murakami K., Nakayama K. J. Biol. Chem. 274:2780-2785(1999) [PubMed] [Europe PMC] [Abstract] Cited for: OLIGOMERIZATION. |
| [12] | "Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells." Smirnova E., Griparic L., Shurland D.-L., van der Bliek A.M. Mol. Biol. Cell 12:2245-2256(2001) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION, MUTAGENESIS OF LYS-38; VAL-41; THR-59 AND GLY-281, OLIGOMERIZATION. |
| [13] | "Dynamin-like protein 1 is involved in peroxisomal fission." Koch A., Thiemann M., Grabenbauer M., Yoon Y., McNiven M.A., Schrader M. J. Biol. Chem. 278:8597-8605(2003) [PubMed] [Europe PMC] [Abstract] Cited for: MUTAGENESIS OF LYS-38, SUBCELLULAR LOCATION, FUNCTION. |
| [14] | "The dynamin-like GTPase DLP1 is essential for peroxisome division and is recruited to peroxisomes in part by PEX11." Li X., Gould S.J. J. Biol. Chem. 278:17012-17020(2003) [PubMed] [Europe PMC] [Abstract] Cited for: MUTAGENESIS OF SER-39 AND THR-59, FUNCTION, SUBCELLULAR LOCATION. |
| [15] | "Intra- and intermolecular domain interactions of the C-terminal GTPase effector domain of the multimeric dynamin-like GTPase Drp1." Zhu P.P., Patterson A., Stadler J., Seeburg D.P., Sheng M., Blackstone C. J. Biol. Chem. 279:35967-35974(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION OF STRUCTURAL DOMAINS, OLIGOMERIZATION, SUBCELLULAR LOCATION, MUTAGENESIS OF LYS-38 AND LYS-679. |
| [16] | "A novel mitochondrial ubiquitin ligase plays a critical role in mitochondrial dynamics." Yonashiro R., Ishido S., Kyo S., Fukuda T., Goto E., Matsuki Y., Ohmura-Hoshino M., Sada K., Hotta H., Yamamura H., Inatome R., Yanagi S. EMBO J. 25:3618-3626(2006) [PubMed] [Europe PMC] [Abstract] Cited for: UBIQUITINATION BY MARCH5, INTERACTION WITH MARCH5. |
| [17] | "MARCH-V is a novel mitofusin 2- and Drp1-binding protein able to change mitochondrial morphology." Nakamura N., Kimura Y., Tokuda M., Honda S., Hirose S. EMBO Rep. 7:1019-1022(2006) [PubMed] [Europe PMC] [Abstract] Cited for: UBIQUITINATION BY MARCH5, INTERACTION WITH MARCH5. |
| [18] | "Inhibiting the mitochondrial fission machinery does not prevent Bax/Bak-dependent apoptosis." Parone P.A., James D.I., Da Cruz S., Mattenberger Y., Donze O., Barja F., Martinou J.C. Mol. Cell. Biol. 26:7397-7408(2006) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [19] | "Mitotic phosphorylation of dynamin-related GTPase Drp1 participates in mitochondrial fission." Taguchi N., Ishihara N., Jofuku A., Oka T., Mihara K. J. Biol. Chem. 282:11521-11529(2007) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION, FUNCTION. |
| [20] | "Cyclic AMP-dependent protein kinase phosphorylation of Drp1 regulates its GTPase activity and mitochondrial morphology." Chang C.R., Blackstone C. J. Biol. Chem. 282:21583-21587(2007) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT SER-637, FUNCTION, SUBUNIT, MUTAGENESIS OF SER-637. |
| [21] | "The mitochondrial E3 ubiquitin ligase MARCH5 is required for Drp1 dependent mitochondrial division." Karbowski M., Neutzner A., Youle R.J. J. Cell Biol. 178:71-84(2007) [PubMed] [Europe PMC] [Abstract] Cited for: SUBCELLULAR LOCATION. |
| [22] | "A lethal defect of mitochondrial and peroxisomal fission." Waterham H.R., Koster J., van Roermund C.W., Mooyer P.A., Wanders R.J., Leonard J.V. N. Engl. J. Med. 356:1736-1741(2007) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, VARIANT EMPF ASP-395, CHARACTERIZATION OF VARIANT EMPF ASP-395. |
| [23] | "CaM kinase I alpha-induced phosphorylation of Drp1 regulates mitochondrial morphology." Han X.J., Lu Y.F., Li S.A., Kaitsuka T., Sato Y., Tomizawa K., Nairn A.C., Takei K., Matsui H., Matsushita M. J. Cell Biol. 182:573-585(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT SER-637, FUNCTION, INTERACTION WITH FIS1, MUTAGENESIS OF SER-637. |
| [24] | "Phosphoproteome of resting human platelets." Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J., Schuetz C., Walter U., Gambaryan S., Sickmann A. J. Proteome Res. 7:526-534(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-616, MASS SPECTROMETRY. Tissue: Platelet. |
| [25] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-548; SER-607 AND SER-616, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [26] | "Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria." Cereghetti G.M., Stangherlin A., Martins de Brito O., Chang C.R., Blackstone C., Bernardi P., Scorrano L. Proc. Natl. Acad. Sci. U.S.A. 105:15803-15808(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT SER-616 AND SER-637, INTERACTION WITH PPP3CA, DEPHOSPHORYLATION, FUNCTION, SUBCELLULAR LOCATION, MUTAGENESIS OF SER-616 AND SER-637. |
| [27] | "MAPL is a new mitochondrial SUMO E3 ligase that regulates mitochondrial fission." Braschi E., Zunino R., McBride H.M. EMBO Rep. 10:748-754(2009) [PubMed] [Europe PMC] [Abstract] Cited for: SUMOYLATION BY MUL1. |
| [28] | "SUMOylation of the mitochondrial fission protein Drp1 occurs at multiple nonconsensus sites within the B domain and is linked to its activity cycle." Figueroa-Romero C., Iniguez-Lluhi J.A., Stadler J., Chang C.R., Arnoult D., Keller P.J., Hong Y., Blackstone C., Feldman E.L. FASEB J. 23:3917-3927(2009) [PubMed] [Europe PMC] [Abstract] Cited for: SUMOYLATION AT LYS-532; LYS-535; LYS-558; LYS-568; LYS-594; LYS-597; LYS-606 AND LYS-608, INTERACTION WITH UBE2I, FUNCTION, MUTAGENESIS OF LYS-38; LYS-532; LYS-535; LYS-558; LYS-568; LYS-594; LYS-597; LYS-606 AND LYS-608. |
| [29] | "Translocation of SenP5 from the nucleoli to the mitochondria modulates DRP1-dependent fission during mitosis." Zunino R., Braschi E., Xu L., McBride H.M. J. Biol. Chem. 284:17783-17795(2009) [PubMed] [Europe PMC] [Abstract] Cited for: SUMOYLATION, DESUMOYLATION, FUNCTION. |
| [30] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-616, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [31] | "S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury." Cho D.H., Nakamura T., Fang J., Cieplak P., Godzik A., Gu Z., Lipton S.A. Science 324:102-105(2009) [PubMed] [Europe PMC] [Abstract] Cited for: S-NITROSYLATION AT CYS-644, FUNCTION, ASSOCIATION WITH ALZHEIMER DISEASE, MUTAGENESIS OF CYS-300; CYS-345; CYS-361; CYS-367; CYS-431; CYS-446; CYS-470; CYS-505 AND CYS-644. |
| [32] | "Dynamin-like protein 1 at the Golgi complex: A novel component of the sorting/targeting machinery en route to the plasma membrane." Bonekamp N.A., Vormund K., Jacob R., Schrader M. Exp. Cell Res. 316:3454-3467(2010) [PubMed] [Europe PMC] [Abstract] Cited for: POSSIBLE FUNCTION, SUBCELLULAR LOCATION. |
| [33] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-616, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [34] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [35] | "MiD49 and MiD51, new components of the mitochondrial fission machinery." Palmer C.S., Osellame L.D., Laine D., Koutsopoulos O.S., Frazier A.E., Ryan M.T. EMBO Rep. 12:565-573(2011) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH MID49 AND MID51. |
| [36] | "Human MIEF1 recruits Drp1 to mitochondrial outer membranes and promotes mitochondrial fusion rather than fission." Zhao J., Liu T., Jin S., Wang X., Qu M., Uhlen P., Tomilin N., Shupliakov O., Lendahl U., Nister M. EMBO J. 30:2762-2778(2011) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH MID51. |
| [37] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-616, MASS SPECTROMETRY. |
| [38] | "The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways." Wang Z., Jiang H., Chen S., Du F., Wang X. Cell 148:228-243(2012) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH PGAM5, SUBCELLULAR LOCATION. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AB006965 mRNA. Translation: BAA22193.1. AF061795 mRNA. Translation: AAC35283.1. AF000430 mRNA. Translation: AAC23724.1. AF151685 mRNA. Translation: AAD39541.1. AK299926 mRNA. Translation: BAG61760.1. AK291094 mRNA. Translation: BAF83783.1. AC084824 Genomic DNA. No translation available. AC087588 Genomic DNA. No translation available. BC024590 mRNA. Translation: AAH24590.1. |
| IPI | IPI00037283. IPI00146935. IPI00473085. IPI00555883. IPI00871742. IPI00942042. |
| PIR | JC5695. |
| RefSeq | NP_005681.2. NM_005690.3. NP_036192.2. NM_012062.3. NP_036193.2. NM_012063.2. |
| UniGene | Hs.556296. |
3D structure databases | |
| ProteinModelPortal | O00429. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | O00429. 7 interactions. |
| MINT | MINT-1394198. |
| STRING | 9606.ENSP00000266481. |
PTM databases | |
| PhosphoSite | O00429. |
Proteomic databases | |
| PaxDb | O00429. |
| PRIDE | O00429. |
Protocols and materials databases | |
| DNASU | 10059. |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000266481; ENSP00000266481; ENSG00000087470. ENST00000452533; ENSP00000415131; ENSG00000087470. ENST00000547312; ENSP00000448610; ENSG00000087470. ENST00000549701; ENSP00000450399; ENSG00000087470. ENST00000553257; ENSP00000449089; ENSG00000087470. |
| GeneID | 10059. |
| KEGG | hsa:10059. |
| UCSC | uc001rld.2. human. uc001rle.2. human. uc001rlf.2. human. |
Organism-specific databases | |
| CTD | 10059. |
| GeneCards | GC12P032832. |
| H-InvDB | HIX0010537. |
| HGNC | HGNC:2973. DNM1L. |
| HPA | CAB009952. |
| MIM | 603850. gene. 614388. phenotype. |
| neXtProt | NX_O00429. |
| PharmGKB | PA27441. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | COG0699. |
| HOVERGEN | HBG107833. |
| KO | K01528. |
| OrthoDB | EOG4SN1N7. |
| PhylomeDB | O00429. |
Enzyme and pathway databases | |
| Reactome | REACT_578. Apoptosis. |
Gene expression databases | |
| ArrayExpress | O00429. |
| Bgee | O00429. |
| CleanEx | HS_DNM1L. |
| Genevestigator | O00429. |
| GermOnline | ENSG00000087470. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR022812. Dynamin. IPR000375. Dynamin_central. IPR001401. Dynamin_GTPase. IPR019762. Dynamin_GTPase_CS. IPR003130. GED. IPR020850. GTPase_effector_domain_GED. [Graphical view] |
| PANTHER | PTHR11566. PTHR11566. 1 hit. |
| Pfam | PF01031. Dynamin_M. 1 hit. PF00350. Dynamin_N. 1 hit. PF02212. GED. 1 hit. [Graphical view] |
| PRINTS | PR00195. DYNAMIN. |
| SMART | SM00053. DYNc. 1 hit. SM00302. GED. 1 hit. [Graphical view] |
| PROSITE | PS00410. DYNAMIN. 1 hit. PS51388. GED. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| ChiTaRS | DNM1L. human. |
| GenomeRNAi | 10059. |
| NextBio | 38007. |
| PMAP-CutDB | O00429. |
| SOURCE | Search... |
Entry information
| Entry name | DNM1L_HUMAN | ||||||||
| Accession | Primary (citable) accession number: O00429 Secondary accession number(s): A8K4X9 Q9Y5J2 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 12 Human chromosome 12: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
